Alpenglow Biosciences
alpenglowbiosciences.com
Actively hiring
Medical Imaging Systems
Artificial Intelligence
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$4.6M
9 rounds on record
Latest round
$4.6M
Venture round · Jun 2021 · 5 yr ago
Team
51-200
employees, estimated range
Grants
$3.4M
5 grants · CORDIS
The money's age
Long since its last round
64 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 20, 2025
Launched Alpenglow Biosciences Unveils LUMI: A Revolutionary Imaging Interface at ABRF 2025 · uk.finance.yahoo.com
Jul 8, 2024
Won a grant $2M · CORDIS
Mar 7, 2024
Took on debt financing $3M · SEC Form D
Apr 1, 2022
Won a grant $253k · CORDIS
Sep 20, 2021
Won a grant $269k · CORDIS
Jul 1, 2021
Won a grant $398k · CORDIS
Sep 5, 2020
Won a grant $398k · CORDIS
Sep 3, 2019
Took on debt financing $300k · SEC Form D
Dec 21, 2018
Took on debt financing $100k · SEC Form D
2018
Founded
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Jul 2024 | $2M | — | CORDIS |
| Debt Financing | Mar 2024 | $3M | — | SEC Form D |
| Grant | Apr 2022 | $253k | — | CORDIS |
| Grant | Sep 2021 | $269k | — | CORDIS |
| Grant | Jul 2021 | $398k | — | CORDIS |
| Venture round | Jun 2021 | $4.6M | — | SEC Form D |
| Grant | Sep 2020 | $398k | — | CORDIS |
| Debt Financing | Sep 2019 | $300k | — | SEC Form D |
| Debt Financing | Dec 2018 | $100k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Alpenglow Biosciences, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Alex SpringerExecutive OfficerSEC Form D
Michael DuttonExecutive OfficerSEC Form D
Nicholas RederExecutive Officer, DirectorSEC Form D
Steven BuckleyDirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
backs Medmain, Lily MedTech
backs Micsi
Similar startupsby what they do, their industry and backers
Pramana is a health-tech company that enables digital transformation for next-generation pathology at medical centers and pathology labs…
PathPresenter is the image sharing platform for pathology on a mission to democratize access to the world’s pathology knowledge by…
Gestalt combines digital pathology, AI, and enterprise IT services to support efficient, enterprise-grade clinical operations.
Franklin.ai develops artificial intelligence software for digital pathology. Its algorithms assist pathologists in grading and detecting…
Medmain develops cloud-based digital pathology and AI diagnostic products that enable remote analysis of whole-slide images. Its flagship…
Don't settle for 2D spatial biology. Discover the power of automated 3D spatial multiomics with Stellaromics Pyxa platform.
News
3D pathology-guided microdissection
Traditional micro- and macrodissection techniques enable the extraction of localized regions in thin tissue sections for molecular analysis. Despite the growing use of three-dimensional (3D) microscopy, analogous methods for volumetric microdissection are
Read more
Report
Alpenglow Biosciences Introduces Summit AI for Quantitative Analysis of Whole Tissue Imaging in Dermatology
Read more
Report
Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: "Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D"
Read more
Report
Alpenglow Biosciences lands new contracts to develop 3D pathology tech
Alpenglow Biosciences, a Seattle biotech startup that develops 3D spatial biology imaging technology, announced Thursday that it landed a $2 million
Read more
Report
Alpenglow Biosciences and Partners Secure a Total of $24M for Development of Alpenglow's 3D Spatial Pathology Platform
Read more
Report
Alpenglow Biosciences and Partners Secure a Total of $24M for Development of Alpenglow's 3D Spatial Pathology Platform
Read more
Report
Alpenglow Biosciences, Inc. Sponsors Dinner Lecture titled "Decoding Immune Exclusion and Tumor Evasion in the TME", featuring Dr. Laura Dillon, PhD of Incendia Therapeutics
Read more
Report
Alpenglow Biosciences awarded $1.6M grant to develop AI-enabled smart microscopy and 3D database of cancer biopsies
Alpenglow is an inaugural recipient of Andy Hill grant, Washington
Read more
Report
People
Alex Springer
Executive Officer
Michael Dutton
Executive Officer
Nicholas Reder
Executive Officer, Director
Steven Buckley
Director
Daniella Kranjac
Director
Jonathan Liu
Director
Gustavo Mahler
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Seattle
United States
HQ
2121 N 35th St, Suite 100
50-200 est. staff
2121 N 35th St, Suite 100, Seattle, WA 98103
Financials
Total raised
$11.3M
Latest round
Grant
Funding rounds
9
Funding rounds